---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-072550"
form_type: "8-K"
ticker: "PRAX"
cik: "0001689548"
company_name: "Praxis Precision Medicines, Inc."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T21:24:13.993315+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Praxis Precision Medicines announces $63.3M public offering of common stock and pre-funded warrants at $0.95/share

## Summary
- Offering includes 55.15M shares of common stock and pre-funded warrants to purchase 7.05M shares at $0.95/$0.9499 per share.
- Underwriters fully exercised option to purchase additional 9.3M shares; net proceeds expected ~$63.3M.
- Proceeds to advance ulixacaltamide Phase 3 for essential tremor and continue PRAX-562, PRAX-222, PRAX-628 epilepsy trials.
- Company expects combined cash and proceeds to fund operations into Q1 2025.
- Closing expected June 21, 2023 subject to customary conditions; pre-funded warrants not listed on Nasdaq.

## SEC filing metadata
- accession: 0001104659-23-072550
- form_type: 8-K
- ticker: PRAX
- cik: 0001689548
- company_name: Praxis Precision Medicines, Inc.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689548/000110465923072550/0001104659-23-072550-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689548/000110465923072550/tm238261d5_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-072550
- JSON: https://secwatch.observer/filing/0001104659-23-072550.json
- Plain text: https://secwatch.observer/filing/0001104659-23-072550.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.